The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following reports of a possible link with cases of blood clots.
The Netherlands officially halts the use of the Oxford–AstraZeneca vaccine for those aged under 60 years old due to concern over rare severe blood clotting.
The Foodand DrugAdministrationsuspends the use of the Oxford–AstraZeneca vaccine for those aged under 60 years old in thePhilippinesfollowingreports ofpossible linkwithrare casesofblood clots.
The Netherlandsofficially suspends the use of the Oxford–AstraZeneca vaccine inpeople under 60 years old due toconcerns over reports of severe blood clotting.
The Foodand DrugAdministration suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following reports of apossiblelinkwithrare casesofblood clots.
The Netherlandsofficially suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old duetoconcernsoverreports of severe blood clotting.
The Foodand DrugAdministration suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following reports of apossiblelinkwithcasesofblood clots.